in a double-blind cross-over study we compared the effects of insulin plus glibenclamide , 5 mg twice daily , with insulin plus placebo during 8-week periods on metabolic parameters in 13 non-insulin dependent diabetic ( niddm ) patients poorly controlled with insulin alone .
C0017628
glibenclamide
C0011860
non-insulin dependent diabetic